Novel models for defining function of the BAFF/APRIL cytokine family
用于定义 BAFF/APRIL 细胞因子家族功能的新模型
基本信息
- 批准号:8787449
- 负责人:
- 金额:$ 8.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-01-01 至 2016-12-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntibodiesAutoimmune DiseasesAutoimmunityB cell differentiationB-LymphocytesBindingBiological Response Modifier TherapyBiologyBone MarrowCell SurvivalCell surfaceCellsClinicalDevelopmentDisadvantagedDiseaseDrug TargetingDsRedEvaluationFamilyFlow CytometryFundingGoalsHealthHomeostasisHomologous GeneHumanImmune responseImmune systemImmunoglobulin AImmunoglobulin Class SwitchingInflammationLaboratoriesLearningLupusMalignant NeoplasmsMediator of activation proteinMethodsModelingMusPatientsPhase III Clinical TrialsPlasma CellsRelative (related person)ReporterRestRoleScientistSerumSourceStagingSumSystemic Lupus ErythematosusTNF geneTestingautoreactive B cellbelimumabcell typecytokinedesigndrug developmenthuman ANP32B proteinimmune activationimmune functioninsightinterestlupus-likeneonatenoveloverexpressionprogramsreceptorresearch studyresponsetherapeutic targettool
项目摘要
DESCRIPTION (provided by applicant): BAFF and its homolog APRIL are TNF-like cytokines that support the survival and differentiation of B cells. BAFF binds to three receptors, BAFF-R, TACI, and BCMA that are expressed on B cells at different developmental stages, whereas APRIL binds only to TACI and BCMA. Overexpression of BAFF causes a lupus-like illness in animal models and high levels of BAFF are found in several autoimmune diseases. Therefore the BAFF/APRIL family has been a target of extensive drug development over the last decade, culminating in the approval in 2011 of the anti-BAFF antibody belimumab for the treatment of lupus. Although much has been learned about this family of cytokines over the last decade, important questions remain about the mechanism of action of BAFF inhibition, the precise role of APRIL and the relative role of each of the three receptors, especially TACI. The experiments proposed here are designed to give us tools that will yield new insights into the basic biology of BAFF and APRIL and their receptors and thereby suggest ways in which therapeutic targeting of these cytokines may be most beneficial for patients. We will therefore generate two new models, an APRIL reporter mouse that allows us to visualize where APRIL protein is being made and a conditionally deficient TACI mouse that allows us to determine the role of TACI on specific cell types. These mice, together with tools we already have, will allow us to better defin the microenvironments in which BAFF and APRIL are expressed during homeostasis and during immune activation, and to better understand the relative importance of TACI in regulating B cell responses.
描述(由申请人提供):BAFF及其同系物APRIL是支持B细胞存活和分化的TNF样细胞因子。BAFF结合三种受体,BAFF-R、TACI和BCMA,它们在不同发育阶段的B细胞上表达,而APRIL仅结合TACI和BCMA。BAFF的过表达在动物模型中引起狼疮样疾病,并且在几种自身免疫性疾病中发现高水平的BAFF。因此,在过去十年中,BAFF/APRIL家族一直是广泛药物开发的目标,最终在2011年批准抗BAFF抗体贝利木单抗用于治疗狼疮。虽然在过去的十年中已经了解了很多关于这个家族的细胞因子,重要的问题仍然是关于BAFF抑制的作用机制,APRIL的确切作用和三种受体中每一种的相对作用,特别是TACI。这里提出的实验旨在为我们提供工具,使我们对BAFF和APRIL及其受体的基础生物学产生新的见解,从而提出这些细胞因子的治疗靶向可能对患者最有益的方法。因此,我们将产生两个新的模型,一个APRIL报告小鼠,使我们能够可视化APRIL蛋白的产生位置,一个条件缺陷TACI小鼠,使我们能够确定TACI对特定细胞类型的作用。这些小鼠与我们已经拥有的工具一起,将使我们能够更好地定义BAFF和APRIL在稳态和免疫激活期间表达的微环境,并更好地理解TACI在调节B细胞应答中的相对重要性。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anne Davidson其他文献
Anne Davidson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anne Davidson', 18)}}的其他基金
Dissecting the heterogeneity and function of myeloid cells in lupus nephritis
剖析狼疮性肾炎骨髓细胞的异质性和功能
- 批准号:
10588862 - 财政年份:2023
- 资助金额:
$ 8.43万 - 项目类别:
T32 Training Grant in Translational Immunology
T32 转化免疫学培训补助金
- 批准号:
10470893 - 财政年份:2021
- 资助金额:
$ 8.43万 - 项目类别:
Mechanisms for Human TLR8 induced pregnancy loss in a mouse model of SLE
人 TLR8 诱导 SLE 小鼠模型妊娠失败的机制
- 批准号:
10301657 - 财政年份:2021
- 资助金额:
$ 8.43万 - 项目类别:
T32 Training Grant in Translational Immunology
T32 转化免疫学培训补助金
- 批准号:
10653079 - 财政年份:2021
- 资助金额:
$ 8.43万 - 项目类别:
Mechanisms for Human TLR8 induced pregnancy loss in a mouse model of SLE
人 TLR8 诱导 SLE 小鼠模型妊娠失败的机制
- 批准号:
10434117 - 财政年份:2021
- 资助金额:
$ 8.43万 - 项目类别:
Induction of lupus-related autoantibodies by TNF inhibitors
TNF 抑制剂诱导狼疮相关自身抗体
- 批准号:
10405223 - 财政年份:2021
- 资助金额:
$ 8.43万 - 项目类别:
T32 Training Grant in Translational Immunology
T32 转化免疫学培训补助金
- 批准号:
10269999 - 财政年份:2021
- 资助金额:
$ 8.43万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 8.43万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 8.43万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 8.43万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 8.43万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 8.43万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 8.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 8.43万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 8.43万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 8.43万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 8.43万 - 项目类别:














{{item.name}}会员




